Newsfeeds - Spark Newswire

1 minute read

SVB Leerink Maintains Market Perform on Adaptimmune Therapeutics, Raises Price Target to $7

Today, 11:48 AM

SVB Leerink analyst Jonathan Chang maintains Adaptimmune Therapeutics (NASDAQ:ADAP) with a Market Perform and raises the price target from $6 to $7.

ADAP

1 minute read

12 Health Care Stocks Moving In Monday’s Pre-Market Session

By Benzinga Insights

Today, 11:48 AM

ADAP

1 minute read

Adaptimmune To Present Updated Data From Phase 1 SURPASS Trial At European Society For Medical Oncology Annual Meeting

By Bill Haddad

Today, 11:48 AM

Adaptimmune Therapeutics plc (NASDAQ:ADAP), a leader in cell therapy to treat cancer, announced updated data from its Phase 1 SURPASS trial in multiple solid tumors to be presented in a digital poster at the

ADAP

6 minute read

72 Biggest Movers From Yesterday

By Lisa Levin

Today, 11:48 AM

Gainers Mechel PAO (NYSE: MTL) shares climbed 56.3% to settle at $5.00 on Tuesday. The company recently reported Q2results, including a 43% quarter-over-quarter revenue growth.

ABOS

2 minute read

Mid-Afternoon Market Update: Dow Falls Over 200 Points; RenovoRx Shares Spike Higher

By Lisa Levin

Today, 11:48 AM

Toward the end of trading Tuesday, the Dow traded down 0.65% to 35,138.64 while the NASDAQ rose 0.13% to 15,383.18. The S&P also fell, dropping 0.27% to 4,522.99.

ADAP

2 minute read

12 Health Care Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights

Today, 11:48 AM

ABOS

4 minute read

45 Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin

Today, 11:48 AM

Gainers IronNet, Inc. (NYSE: IRNT) shares jumped 50.4% to $25.06 after jumping over 23% on Friday.

ABOS

1 minute read

SVB Leerink Maintains Market Perform on Adaptimmune Therapeutics, Raises Price Target to $6

By vishwanath@benzinga.com

Today, 11:48 AM

SVB Leerink analyst Jonathan Chang maintains Adaptimmune Therapeutics (NASDAQ:ADAP) with a Market Perform and raises the price target from $5 to $6.

ADAP

1 minute read

12 Health Care Stocks Moving In Tuesday’s Pre-Market Session

By Benzinga Insights

Today, 11:48 AM

ADAP

1 minute read

Adaptimmune Stock Moves Higher On Cancer Deal With Genentech

By Vandana Singh

Today, 11:48 AM

Adaptimmune Therapeutics plc (NASDAQ:ADAP) has announced a collaboration and license agreement with Genentech, a unit of Roche Holdings AG (OTC:RHHBY), to develop and commercialize…

ADAP